多焦点肝细胞癌不同亚型的分子进化
Xia Tang1, Lei Xiang2, Qingshu Li3
1Shanghai Pudong Hospital and Pudong Medical Center of Fudan University, State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, 200438, People's Republic of China.
Hepatology international
|June 5, 2023
概括
多焦点肝细胞癌 (MF-HCC) 亚型表现出明显的分子进化,早期转移播种和常见的 preneoplastic 克隆被确定. 这项研究有助于为MF-HCC患者制定个性化管理策略.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 多焦点肝细胞癌 (MF-HCC) 占肝癌病例的40%以上,预后比单一原发性瘤差.
- 了解MF-HCC亚型的分子特征,克隆进化和转移时间对于开发向疗法至关重要.
研究的目的:
- 描述不同MF-HCC亚型的分子进化,突变特征,转移时间和前性遗传足迹.
- 确定克隆进化中的关键差异,为MF-HCC提供个性化管理策略.
主要方法:
- 来自35名MF-HCC患者的74个瘤样本的整体外组测序,包括前瘤病变和相邻的非癌性组织.
- 对瘤异质性,肝内转移时间和分子足迹的分析,并使用独立的MF-HCC队列进行验证.
主要成果:
- 多发性肝炎患者被分为三个亚型:肝内转移,多中心发生和混合.
- 多样化的突变特征表明了不同的病因和亚型的克隆进展,在肝脏内转移中观察到早期的转移性播种.
- 多中心发生的亚型显示出常见的前性克隆,是多种病变的祖先.
结论:
- 该研究全面详细介绍了MF-HCC亚型中的多种瘤克隆进化史.
- 研究结果为优化MF-HCC个性化临床管理和治疗策略提供了关键的见解.
相关概念视频
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancers Originate from Somatic Mutations in a Single Cell
12.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.3K


